EP Wealth Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$448K Sell
1,678
-370
-18% -$100K ﹤0.01% 950
2025
Q4
$514K Buy
+2,048
New +$544K ﹤0.01% 868
2025
Q2
$444K Buy
1,690
+84
+5% +$20.5K ﹤0.01% 828
2025
Q1
$374K Buy
1,606
+277
+21% +$67.2K ﹤0.01% 820
2024
Q4
$305K Sell
1,329
-91
-6% -$20.9K ﹤0.01% 865
2024
Q3
$317K Buy
1,420
+194
+16% +$42.6K ﹤0.01% 833
2024
Q2
$250K Buy
1,226
+261
+27% +$53.1K ﹤0.01% 703
2024
Q1
$211K Buy
+965
New +$213K ﹤0.01% 722
2022
Q3
Sell
-996
Closed -$201K 497
2022
Q2
$201K Buy
+996
New +$212K ﹤0.01% 573

Other funds holding LH

EP Wealth Advisors's LH Position: Q1 2026 in Review

EP Wealth Advisors reduced its Labcorp (LH) stake by 18% in Q1 2026, selling an estimated $100K and leaving 1,678 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #950.

EP Wealth Advisors first reported a position in LH in Q2 2022 and has held it in 9 quarters since. The position peaked at $514K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • EP Wealth Advisors held 1,678 shares of Labcorp worth $448K as of Q1 2026.
  • EP Wealth Advisors sold 370 Labcorp shares in Q1 2026, an estimated $100K.
  • Labcorp made up ﹤0.01% of EP Wealth Advisors's portfolio in Q1 2026, its #950 holding.
  • EP Wealth Advisors first reported a position in Labcorp in Q2 2022 and has held it in 9 quarters since.
  • EP Wealth Advisors's Labcorp position peaked at $514K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.